Novo Nordisk to launch lower-cost Ozempic copy in South Africa - Reuters
Novo Nordisk to launch lower-cost Ozempic copy in South Africa Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQampBYmR5UzBvNXdoNlYzbUw3d1lLMktmS1FjUnVvVFNPMFlidmN4eTBaN1JOTjJuLThnNHZ1YmhORkJfemFIZG5mT1RBRnV5Z3hILWo0SGFaRFhnQ2NyWEJ0dnNrSVI4NTVjMG8tY2w2NFAxMFBoaHpjY0RVWG9ZcWtkVmRxdHVLR1lFczFpVWpTWXFRSWFpTEZhWk9KM3ZUbF8yOVNBejdJLU9nemc?oc=5" target="_blank">Novo Nordisk to launch lower-cost Ozempic copy in South Africa</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMAfrica's biggest IPO exposes continent's cross-border investing barriers - Reuters
Africa's biggest IPO exposes continent's cross-border investing barriers Reuters
October 9, 2026 at 05:03 AMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMPepsiCo to cut costs as weak N.America business hurts core profit forecast - Reuters
PepsiCo to cut costs as weak N.America business hurts core profit forecast Reuters
October 8, 2026 at 11:26 AMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PM